Adtalem Global Education Inc. ATGE posted impressive third-quarter fiscal 2025 results, wherein adjusted earnings and revenues topped the Zacks Consensus Estimate and increased year over year. The quarter’s performance was driven by robust performance across all the company’s reportable segments, resulting in top-line growth. The segments’ performances were mainly backed by increased enrollment and higher tuition rates. Also, ATGE’s focus on strategic investments to boost student experience is boding well. Following the results, shares of this leading education provider gained 2.4% in the after-hours trading session yesterday. Adtalem's operational excellence strategy, Growth with Purpose, has driven seven consecutive quarters of enrollment growth while supporting its mission to develop skilled healthcare professionals. Owing to the trend of results and favorable aspects, the company remains optimistic about ending fiscal 2025 on a stronger note. ATGE’s Earnings & Revenue Discussion The company’s adjusted earnings per share (EPS) of $1.92 topped the Zacks Consensus Estimate of $1.63 by 17.8%. In the year-ago quarter, it reported an adjusted EPS of $1.50. Revenues of $466.1 million also surpassed the consensus mark of $444 million by 4.9% and grew 12.9% year over year. (Find the latest earnings estimates and surprises on Zacks Earnings Calendar.) Adtalem Global Education Inc. Price, Consensus and EPS SurpriseAdtalem Global Education Inc. Price, Consensus and EPS Surprise Adtalem Global Education Inc. price-consensus-eps-surprise-chart | Adtalem Global Education Inc. Quote In the fiscal third quarter, enrollment of total students rose 9.8% year over year to 94,223 students. Our Zacks model predicted a total student enrollment of 88,056 for the quarter. Adjusted operating income increased 17.4% from the prior-year quarter’s level to $105.4 million. Adjusted operating margin expanded 80 basis points (bps) to 22.6%. Adjusted EBITDA was $127.8 million, up 19.3% from the prior-year quarter’s level. Adjusted EBITDA margin expanded 150 bps year over year to 27.4%. We expected the adjusted EBITDA margin to be 24.7% for the reported quarter. Adtalem's Segment Details Chamberlain: Revenues in the segment were up 13.1% from the year-ago quarter’s level, totaling $192.6 million. Total student enrollment increased 6.8% to 40,564 students, driven by growth in pre-licensure and post-licensure nursing programs. Adjusted operating income increased 9.6% from the prior-year quarter’s level to $47.5 million. Adjusted operating margin contracted 70 bps to 24.7%. Adjusted EBITDA was $56.8 million, up 12.6% from the prior-year quarter’s level. Adjusted EBITDA margin contracted 10 bps to 29.5%. Walden: The segment generated revenues of $178.4 million, up 18.5% year over year. Total student enrollment in the quarter increased 13.5% year over year to 48,526 students, driven by investments in student experience, accompanied by providing flexibility to working adults through part-time and Tempo Learning competency-based programs. Adjusted operating income surged 50.6% from the prior-year quarter’s figure to $48 million. Adjusted operating margin expanded 570 bps to 26.9%. Adjusted EBITDA was $54 million, significantly up 50.6% from the prior-year quarter’s level. Adjusted EBITDA margin rose 650 bps to 30.3%. Medical and Veterinary: Revenues in the segment increased 3.6% to $95 million from the year-ago quarter’s figure. Total student enrollment inched up 1.2% from the prior-year quarter’s level to 5,133 students. Adjusted operating income declined 21.9% from the prior-year quarter’s figure to $17.9 million. Adjusted operating margin contracted 610 bps to 18.9%. Adjusted EBITDA was $22.9 million, down 15.3% from the prior-year quarter’s level. Adjusted EBITDA margin contracted 540 bps to 24%. Story Continues Liquidity & Cash Flow of ATGE As of March 31, 2025, Adtalem had cash and cash equivalents of $219 million compared with $219.3 million as of June 30, 2024. Long-term debt was $552.2 million, down from $648.7 million at fiscal 2024-end. For the first nine months of fiscal 2025, cash provided by operating activities (continuing operations) totaled $273.8 million, up from $227.1 million in the year-ago period. Free cash flow at the end of the fiscal third quarter was $287 million, up from $233 million a year ago. Adtalem Raises Fiscal 2025 Guidance For fiscal 2025, ATGE now expects revenues in the range of $1,760-$1,775 million (compared with $1,730-$1,760 million expected earlier). It now expects adjusted earnings to be in the band of $6.40-$6.60 per share compared with the earlier prediction of $6.10-$6.30. ATGE’s Zacks Rank & Peer Releases Adtalem currently carries a Zacks Rank #3 (Hold). Universal Technical Institute, Inc. UTI reported impressive second-quarter fiscal 2025 results. Both earnings and revenues surpassed the Zacks Consensus Estimate and increased on a year-over-year basis. The company achieved strong growth in the fiscal second quarter, driven by its strategy, focused on expansion, diversification and optimization. Both divisions saw year-over-year improvements in key financial and operational areas. Higher revenues, an increase in active students and strong new enrollments contributed to the bottom-line growth. Owing to strong performance, Universal Technical has raised its guidance for fiscal 2025 while remaining aligned with long-term growth objectives. Strategic Education, Inc. STRA, or SEI, reported impressive results for the first quarter of 2025. Its adjusted earnings and revenues topped the Zacks Consensus Estimate. On a year-over-year basis, both the top and bottom lines increased. Strategic Education’s quarter witnessed robust employer-affiliated enrollment, strong growth from Sophia Learning subscriptions and continued enrollment growth in the U.S. Higher Education (USHE) segment. Sophia Learning’s average total subscribers increased approximately 37% from the year-ago period’s level. Employer-affiliated enrollment reached a record high of 31.2% of USHE enrollment, up from 29.2% in the year-ago period. A Key Schools Pick Laureate Education, Inc. LAUR presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. The company has a trailing four-quarter earnings surprise of 56.1%, on average. Its shares have gained 24.3% in the year-to-date period. The Zacks Consensus Estimate for Laureate’s 2025 sales and EPS indicates growth of 0.3% and 23.7%, respectively, from the year-ago period’s levels. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Strategic Education Inc. (STRA):Free Stock Analysis Report Universal Technical Institute Inc (UTI):Free Stock Analysis Report Laureate Education (LAUR):Free Stock Analysis Report Adtalem Global Education Inc. (ATGE):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Adtalem Stock Gains on Q3 Earnings & Revenue Beat, FY25 View Up
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...